Works matching IS 21641153 AND DT 2025 AND VI 15 AND IP 1
Results: 5
Managing and Mitigating Discontinuation Syndrome With Ruxolitinib and Other Novel JAK Inhibitors for Myelofibrosis.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2025, v. 15, n. 1, p. 36
- By:
- Publication type:
- Article
Posaconazole-Induced Hypokalemia After an Allogeneic Stem-Cell Transplant: 2 Case Reports.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2025, v. 15, n. 1, p. 31
- By:
- Publication type:
- Article
Tisotumab Vedotin With Pembrolizumab in the Treatment of a Patient With Metastatic Vaginal Cancer: A Case Report.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2025, v. 15, n. 1, p. 26
- By:
- Publication type:
- Article
Exploratory Real-World Comparative Analysis of Abiraterone Dosing Strategies.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2025, v. 15, n. 1, p. 19
- By:
- Publication type:
- Article
Safety and Efficacy of Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2025, v. 15, n. 1, p. 12
- By:
- Publication type:
- Article